ClearVue Launches $6M Raise for Operational Scale Up and IP Expansion
ClearVue raises $6 million to fund next-generation building materials and global expansion
ClearVue Technologies has launched a $6 million capital raise before costs, comprising a $5 million institutional Placement and a fully underwritten $1 million Share Purchase Plan (SPP) for existing shareholders. The Placement was priced at $0.115 per share, representing a 14.3% discount to the 30-day VWAP of $0.1342.
The Placement attracted strong support from institutional, sophisticated and professional investors, with 43,478,261 shares issued. Both the Placement and SPP include 1:1 free attaching options exercisable at $0.115 with a three-year term. The SPP is fully underwritten by Alpine Capital and Spark Plus, ensuring the SPP component of $1 million is fully covered.
Eligible shareholders can participate in the SPP on the same terms as institutional investors, including the free attaching options, without incurring brokerage or commission costs. This structure preserves proportional ownership opportunities for existing retail shareholders.
The strengthened balance sheet positions ClearVue to meet increasing due diligence requirements from customers, partners and investors as it scales commercial operations. Financial strength and execution capability are becoming critical factors as customer engagement evolves from technology evaluation to active project delivery.
When big ASX news breaks, our subscribers know first
Where the funds will go
The capital raise will be allocated across three primary areas:
- ERP system implementation, configuration, licensing and roll-out — operational infrastructure to support commercial scaling
- R&D activities, patent filings, prosecution, maintenance and renewals — protecting and expanding the company’s intellectual property portfolio
- Working capital and costs of the Capital Raise — funding general operational requirements and transaction costs
This capital allocation prioritises operational systems and IP protection, both critical for scaling from technology evaluation to commercial project delivery. The ERP system implementation will support the operational infrastructure required as the company transitions to full-scale manufacturing and project execution.
The $6 million raise follows ClearVue’s earlier non-dilutive R&D funding facility secured in March 2026, which drew on R&D tax credits to advance certification milestones without equity dilution, demonstrating the company’s strategy of layering multiple funding sources as it scales.
What is a Share Purchase Plan and why it matters for retail investors
A Share Purchase Plan allows existing shareholders to purchase additional shares without incurring brokerage, transaction or commission costs. Under ClearVue’s SPP, eligible shareholders can subscribe for up to $30,000 worth of shares at a price equal to the lesser of the Placement price ($0.115) or a 2.5% discount to the 5-day VWAP at the closing date.
Eligibility is restricted to registered holders as at 5pm AEST on 19 June 2026 with addresses in Australia, New Zealand, the United Kingdom or Singapore. The SPP offers the same 1:1 free attaching options as the Placement, exercisable at $0.115 with a three-year term.
The Board can accept oversubscriptions at its discretion beyond the $1 million target. Any shortfall will be placed by the Joint Lead Managers using the company’s available placement capacity under ASX Listing Rules 7.1 and 7.1A.
This structure ensures existing shareholders can participate on equivalent terms to institutional investors, preserving proportional ownership opportunity and access to the same capital structure benefits.
New high-performance building materials targeting data centre demand
Managing Director and CEO Doug Hunt outlined the company’s strategic direction towards next-generation insulated building materials designed to redefine the role of the building envelope. The focus is on shifting the building envelope from a passive barrier to an active contributor to energy performance.
AI-driven data centre growth is creating structural demand for advanced building materials that reduce cooling loads, improve operational efficiency and lower lifecycle energy costs. The infrastructure required to train and run AI models is energy-intensive at a scale the industry has not previously encountered, placing buildings that house this infrastructure under significant performance pressure.
Doug Hunt, Managing Director and CEO
“By optimising coatings, materials and product architecture, we see significant potential to deliver superior thermal performance while extending our product platform well beyond our current offering.”
This represents forward-looking strategic direction rather than a launched product. ClearVue is positioning to capture the emerging market opportunity created by AI infrastructure expansion. As AI adoption continues to accelerate worldwide, the company aims to develop technologies that address the growing need for high-performance building materials in energy-intensive applications.
Capital structure and key dates
The capital raise will increase ClearVue’s shares on issue from 307,280,832 to 359,454,745, based on full SPP subscription at the indicative price of $0.115. The final SPP price will not be determined until after the closing date and may be lower, resulting in higher share issuance if the 5-day VWAP discount applies.
| Item | Current | Post-Raise |
|---|---|---|
| Shares on issue | 307,280,832 | 359,454,745* |
| Attaching Options (Placement) | — | 43,478,261 |
| Attaching Options (SPP)* | — | 8,695,652 |
*Based on full SPP subscription at indicative $0.115 price. Final SPP price may be lower, resulting in higher share issuance.
The key dates for the SPP are:
- SPP opens: 29 June 2026
- SPP closes: 13 July 2026 at 5:00pm (AEST)
- SPP shares issued: 20 July 2026
- General Meeting for options approval: Late August/Early September 2026
Placement shares are expected to settle on 24 June 2026 and be issued on 25 June 2026. The Attaching Options for both the Placement and SPP require shareholder approval under ASX Listing Rule 7.1, with a General Meeting scheduled for late August or early September 2026.
Chair acknowledges long-term shareholder support
Chair Theresa Smits recognised the contribution of ClearVue’s retail investor base through the company’s development phases. Many shareholders have supported the company through years of technology development, product validation and commercialisation.
Theresa Smits, Chair
“Many of our shareholders have supported ClearVue through years of technology development, product validation and commercialisation, and their continued belief in the Company’s vision has played an important role in bringing ClearVue to where it is today.”
The Board structured the SPP to provide existing shareholders with the opportunity to participate in the capital raise alongside new institutional investors. This recognises the ongoing support of the retail shareholder base and their role in ClearVue’s progression to its current commercialisation phase.
The next major ASX story will hit our subscribers first
What’s next for ClearVue
With capital secured, execution becomes the primary value driver for ClearVue. The company remains focused on converting its growing pipeline of opportunities into commercial outcomes. The strengthened balance sheet enables the company to meet customer, partner and investor due diligence requirements as engagement evolves from technology evaluation to project delivery.
ClearVue maintains dual listings on the ASX and OTCQX, providing access to both Australian and international investor bases. The company’s investor focus now shifts to pipeline conversion and commercial traction as key performance indicators.
The capital raise positions ClearVue with the financial strength and operational systems required to scale its global commercialisation activities. Product certification and testing, marketing, intellectual property protection and international business development will continue as the company advances its technology portfolio and new product development initiatives.
For investors exploring the R&D pipeline underpinning these new product development initiatives, our detailed coverage of ClearVue’s ARC solar window grant walks through the University of Melbourne partnership, the three-year research programme scope and what the peer-reviewed funding approval signals about the commercial maturity of the underlying technology.
Want the Next Industrials Breakthrough in Your Inbox?
Join 20,000+ investors getting FREE breaking ASX news delivered within minutes of release, complete with in-depth analysis. Click the “Free Alerts” button at StockWire X to receive real-time alerts the moment market-moving announcements drop across Tech, Healthcare, Finance, Consumer, Manufacturing and more.